Literature DB >> 25436195

Interaction of palmitic Acid with metoprolol succinate at the binding sites of bovine serum albumin.

Mashiur Rahman1, Farzana Prianka1, Mohammad Shohel2, Md Abdul Mazid1.   

Abstract

PURPOSE: The aim of this study was to characterize the binding profile as well as to notify the interaction of palmitic acid with metoprolol succinate at its binding site on albumin.
METHODS: The binding of metoprolol succinate to bovine serum albumin (BSA) was studied by equilibrium dialysis method (ED) at 27°C and pH 7.4, in order to have an insight in the binding chemistry of the drug to BSA in presence and absence of palmitic acid. The study was carried out using ranitidine as site-1 and diazepam as site-2 specific probe.
RESULTS: Different analysis of binding of metoprolol succinate to bovine serum albumin suggested two sets of association constants: high affinity association constant (k1 = 11.0 x 10(5) M(-1)) with low capacity (n1 = 2) and low affinity association (k2 = 4.0×10(5) M(-1)) constant with high capacity (n2 = 8) at pH 7.4 and 27°C. During concurrent administration of palmitic acid and metoprolol succinate in presence or absence of ranitidine or diazepam, it was found that palmitic acid displaced metoprolol succinate from its binding site on BSA resulting reduced binding of metoprolol succinate to BSA. The increment in free fraction of metoprolol succinate was from 26.27% to 55.08% upon the addition of increased concentration of palmitic acid at a concentration of 0×10(-5) M to 16×10(-5) M. In presence of ranitidine and diazepam, palmitic acid further increases the free fraction of metoprolol succinate from 33.05% to 66.95% and 40.68% to 72.88%, respectively.
CONCLUSION: This data provided the evidence of interaction at higher concentration of palmitic acid at the binding sites on BSA, which might change the pharmacokinetic properties of metoprolol succinate.

Entities:  

Keywords:  Binding sites; Bovine serum albumin; Equilibrium dialysis; Metoprolol succinate; Palmitic acid

Year:  2014        PMID: 25436195      PMCID: PMC4137429          DOI: 10.5681/apb.2014.056

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  13 in total

1.  The characterization of two specific drug binding sites on human serum albumin.

Authors:  G Sudlow; D J Birkett; D N Wade
Journal:  Mol Pharmacol       Date:  1975-11       Impact factor: 4.436

2.  Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics.

Authors:  Marta Ulldemolins; Jason A Roberts; Steven C Wallis; Jordi Rello; Jeffrey Lipman
Journal:  J Antimicrob Chemother       Date:  2010-06-08       Impact factor: 5.790

3.  Further characterization of specific drug binding sites on human serum albumin.

Authors:  G Sudlow; D J Birkett; D N Wade
Journal:  Mol Pharmacol       Date:  1976-11       Impact factor: 4.436

4.  Atomic structure and chemistry of human serum albumin.

Authors:  X M He; D C Carter
Journal:  Nature       Date:  1992-07-16       Impact factor: 49.962

Review 5.  Protein binding: do we ever learn?

Authors:  Markus A Zeitlinger; Hartmut Derendorf; Johan W Mouton; Otto Cars; William A Craig; David Andes; Ursula Theuretzbacher
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

6.  Characterization of high affinity binding sites of non-steroidal anti-inflammatory drugs with respect to site-specific probes on human serum albumin.

Authors:  M H Rahman; K Yamasaki; Y H Shin; C C Lin; M Otagiri
Journal:  Biol Pharm Bull       Date:  1993-11       Impact factor: 2.233

7.  Development and application of an HPLC method for erlotinib protein binding studies.

Authors:  Soheila Bolandnazar; Adeleh Divsalar; Hadi Valizadeh; Arash Khodaei; Parvin Zakeri-Milani
Journal:  Adv Pharm Bull       Date:  2013-08-20

Review 8.  Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.

Authors:  J H Lin; D M Cocchetto; D E Duggan
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

9.  Effects of aliphatic fatty acids on the binding of Phenol Red to human serum albumin.

Authors:  U Kragh-Hansen
Journal:  Biochem J       Date:  1981-06-01       Impact factor: 3.857

10.  Absorbance correction method for estimation of telmisartan and metoprolol succinate in combined tablet dosage forms.

Authors:  Komal Patel; Amit Patel; Jayant Dave; Chaganbhai Patel
Journal:  Pharm Methods       Date:  2012-07
View more
  2 in total

1.  Interactions Between Sirolimus and Anti-Inflammatory Drugs: Competitive Binding for Human Serum Albumin.

Authors:  Arash Khodaei; Soheila Bolandnazar; Hadi Valizadeh; Leila Hasani; Parvin Zakeri-Milani
Journal:  Adv Pharm Bull       Date:  2016-06-30

2.  Sirolimus-Eluting Electrospun-Produced Matrices as Coatings for Vascular Stents: Dependence of Drug Release on Matrix Structure and Composition of the External Environment.

Authors:  Zhanna K Nazarkina; Boris P Chelobanov; Vera S Chernonosova; Irina V Romanova; Andrey A Karpenko; Pavel P Laktionov
Journal:  Materials (Basel)       Date:  2020-06-12       Impact factor: 3.623

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.